Sotagliflozin, a dual SGLT1/2 inhibitor, increased hemoglobin levels in patients with type 2 diabetes and chronic kidney ...

The 2023 AABB guidelines overall favor a restrictive transfusion strategy, recommending RBC transfusion for hemoglobin <7 ...

A new study published in the journal of BMC Nephrology showed that the effectiveness of roxadustat is comparable at varying ...

The following is a summary of “Erythrocyte indices and response to hypoxia-inducible factor prolyl hydroxylase inhibitors in ...

Digital cognitive behavioral therapy was as effective as pain education at easing sickle cell pain, a study reported.

Chronic lymphocytic leukemia ... but many people live with the disease for several years. Some people even live for many years without needing treatment. However, CLL primarily affects older ...

the differentiation from microcytic hypochromic anemias of chronic disorders and beta-thalassemia minor. With a limited laboratory, the diagnosis of iron-deficiency anemia can be usually made with ...

AKI - the other main type of kidney disease - can be caused by dehydration, blood loss, urinary tract obstructions such as ...

Following a phase 1b trial, the potent and selective dual inhibitor of IRAK1 and IRAK4 received fast track designation for the treatment of patients with lower-risk myelodysplastic syndrome.

Iron deficiency can cause several symptoms, including fatigue, headaches, and brittle nails. Spotting these signs early on can help you prevent complications.

Do you feel bloated, fatigued or have frequent digestive discomfort? Small Intestinal Bacterial Overgrowth (SIBO) affects a ...

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that the U.S. Food and Drug Administration (FDA) has ...